Epigenomics AG (EPGNF)
2.50
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Epigenomics Total Liabilities (Quarterly): 2.508M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 2.508M |
| March 31, 2023 | 7.127M |
| December 31, 2022 | 6.091M |
| September 30, 2022 | 4.951M |
| June 30, 2022 | 4.130M |
| March 31, 2022 | 3.740M |
| December 31, 2021 | 2.879M |
| September 30, 2021 | 3.221M |
| June 30, 2021 | 3.962M |
| March 31, 2021 | 3.540M |
| December 31, 2020 | 3.608M |
| September 30, 2020 | 3.858M |
| June 30, 2020 | 4.188M |
| March 31, 2020 | 8.028M |
| December 31, 2019 | 4.884M |
| September 30, 2019 | 4.418M |
| June 30, 2019 | 4.371M |
| March 31, 2019 | 3.225M |
| December 31, 2018 | 3.676M |
| September 30, 2018 | 11.75M |
| June 30, 2018 | 10.55M |
| March 31, 2018 | 11.11M |
| December 31, 2017 | 11.03M |
| September 30, 2017 | 11.05M |
| June 30, 2017 | 5.007M |
| Date | Value |
|---|---|
| March 31, 2017 | 3.288M |
| December 31, 2016 | 4.015M |
| September 30, 2016 | 6.232M |
| June 30, 2016 | 9.544M |
| March 31, 2016 | 8.710M |
| December 31, 2015 | 6.013M |
| September 30, 2015 | 7.719M |
| June 30, 2015 | 7.187M |
| March 31, 2015 | 6.691M |
| December 31, 2014 | 6.338M |
| September 30, 2014 | 6.054M |
| June 30, 2014 | 6.824M |
| March 31, 2014 | 6.493M |
| December 31, 2013 | 6.382M |
| September 30, 2013 | 2.947M |
| June 30, 2013 | 2.411M |
| March 31, 2013 | 2.832M |
| December 31, 2012 | 3.597M |
| September 30, 2012 | 4.617M |
| June 30, 2012 | 3.872M |
| March 31, 2012 | 3.383M |
| December 31, 2011 | 4.245M |
| September 30, 2011 | 5.604M |
| June 30, 2011 | 3.909M |
| March 31, 2011 | 3.692M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.508M
Minimum
Jun 2023
8.028M
Maximum
Mar 2020
4.441M
Average
4.130M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Affimed NV | 43.50M |
| InflaRx NV | 13.32M |
| MorphoSys AG | 2.186B |
| BioNTech SE | 2.471B |
| Immatics NV | 272.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.583M |
| Shareholders Equity (Quarterly) | 2.075M |
| Current Ratio | 1.934 |